MLAB - メサ・ラボラトリ―ズ （Mesa Laboratories Inc.） メサ・ラボラトリ―ズMLABのチャート
MLABの企業情報
| symbol | MLAB |
|---|---|
| 会社名 | Mesa Laboratories Inc. （メサ・ラボラトリ―ズ） |
| 分野（sector） | Capital Goods 資本財（工業製品） |
| 産業（industry） | Industrial Machinery/Components |
| 業種 | 産業機械_装置 IT・通信（IT_Communications） |
| 概要 | 事業概要 メサ･ラボラトリーズ(Mesa Laboratories Inc.)は品質管理製品およびサービスの提供に従事する。同社は4つの事業を通じて運営する。インスツルメンツ事業は品質管理機器および使い捨て製品を設計、製造、販売する。生物学的測定器事業は試験サービスを提供し、生物学的測定器の製造およびマーケティングを行い、滅菌プロセスの有効性を評価するために使用される化学測定器の販売を行う。継続的監視事業は各種環境パラメータを監視するために使用されるシステムを設計、開発、販売する。コールド・チェーン事業はコールドチェーン製品のパラメータを監視する。同社のブランドには、「DataTrace」、「DialyGuard」、「DryCal」、「Torqo」、「SureTorque」、「BGI」、「Mesa」、「PCD」、「Apex」、「CheckPoint」、「Mesa」、「TempTrust」が含まれる。 メサ・ラボラトリ―ズは、米国の電子計測機器メ―カ―。工業分野や血液透析で利用する電子計測機器を設計、製造、販売する。事業は、器具、生物学的指標、連続モニタリングの3部門で構成。器具部門は、品質管理機器と使い捨て製品を展開。主要製品は、パイプライン流量計、血液透析器や配分器の測定装置、温度センサ―、デ―タ記録計など。 mesa laboratories, inc., develops, manufactures and markets high-quality process validation, monitoring and calibration instruments and consumables worldwide. mesa offers quality data loggers for monitoring temperature, humidity, and pressure and biological indicators (bis) for medical device and pharmaceutical manufacturing sterilization monitoring. the datatrace data loggers and mesa bis are available to monitor and validate applications including steam and eo sterilization, autoclave validation, incubators, heat tunnels and more. mesa’s bi offering also includes bis for industrial use, hydrogen peroxide (h2o2), chlorine dioxide and more. the phoenix meter is a point-of-use dialysate qc meter used prior to each procedure. the 90xl meter is the industry standard for calibration of dialysis machines in the field. also available are industry leading nist-traceable calibration solutions. mesa also offers cap torque testers which are durable, reliable and computerized cap torque analyzers |
| 本社所在地 | 12100 West Sixth Avenue Lakewood CO 80228 USA |
| 代表者氏名 | John J. Sullivan ジョン・サリバン |
| 代表者役職名 | Chairman of the Board 取締役会会長 |
| 電話番号 | +1 303-987-8000 |
| 設立年月日 | 30011 |
| 市場名 | NASDAQ National Market System |
| ipoyear | ―年 |
| 従業員数 | 366人 |
| url | www.mesalabs.com |
| nasdaq_url | https://www.nasdaq.com/symbol/mlab |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 28.43200 |
| 終値（lastsale） | 178.2 |
| 時価総額（marketcap） | 686208105 |
| 時価総額 | 時価総額（百万ドル） 698.91560 |
| 売上高 | 売上高（百万ドル） 98.64800 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 730.92760 |
| 当期純利益 | 当期純利益（百万ドル） -0.30800 |
| 決算概要 | 決算概要 BRIEF: For the three months ended 30 June 2018 Mesa Laboratories Inc. revenues increased 11% to $25.1M. Net income increased from $1.5M to $4.2M. Revenues reflect Sterilization and Disinfection Control segment increase of 11% to $11.3M Cold Chain Packaging segment increase of 90% to $1.8M United States segment increase of 19% to $15.5M. Net income benefited from Selling decrease of 29% to $1.9M (expense). |
MLABのテクニカル分析
MLABのニュース
Evercore ISI maintains Mesa Labs at ''in line'' with a price target of $140.00 2023/05/30 14:23:38 Investing.com
https://www.investing.com/news/pro/mesa-laboratories-receives-investment-bank-analyst-rating-update-3093993
Mesa Laboratories GAAP EPS of $0.11 misses by $0.26, revenue of $55.59M misses by $2.46M 2023/05/25 12:47:39 Seeking Alpha
Mesa Laboratories press release (MLAB): Q1 GAAP EPS of $0.11 misses by $0.26.Revenue of $55.59M (+10.2% Y/Y) misses by $2.46M.
Mesa Labs: Fiscal Q4 Earnings Snapshot 2023/05/25 12:12:40 WTOP
LAKEWOOD, Colo. (AP) — LAKEWOOD, Colo. (AP) — Mesa Laboratories Inc. (MLAB) on Thursday reported profit of $611,000 in its…
Recap: Mesa Laboratories Q4 Earnings 2023/05/25 12:05:53 Benzinga
Mesa Laboratories (NASDAQ: MLAB ) reported its Q4 earnings results on Thursday, May 25, 2023 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Mesa Laboratories beat estimated earnings by 424.32%, reporting an EPS of $1.94 versus an … Full story available on Benzinga.com
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results 2023/05/25 12:00:00 GlobeNewswire
LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (“4Q23”) and fiscal year (“FY23”) ended March 31, 2023.
Mesa Laboratories: Divisional Growth, Valuations Supportive Of Hold 2023/02/28 01:26:32 Seeking Alpha
In Q3, Mesa Laboratories reported mixed results throughout the P&L with soft bottom-line fundamentals. See why MLAB stock is a Hold.
Mesa Laboratories''s Return on Invested Capital Insights 2023/02/07 14:48:05 Benzinga
Pulled from Benzinga Pro data, Mesa Laboratories (NASDAQ: MLAB ) posted Q3 earnings of $451 thousand, an increase from Q2 of 65.47%. Sales dropped to $54.29 million, a 7.6% decrease between quarters. In Q2, Mesa Laboratories earned $1.31 million, and total sales reached $58.75 million. Why Is ROIC Significant? Return on Invested Capital is a measure of yearly pre-tax profit relative to capital invested by a business. Changes in earnings and sales indicate shifts in a company''s ROIC. A higher ROIC is generally representative of successful growth of a company and … Full story available on Benzinga.com
Mesa Laboratories PT Raised to $180 at Evercore ISI 2023/02/06 19:46:01 Investing.com
https://www.investing.com/news/pro/mesa-laboratories-pt-raised-to-180-at-evercore-isi-432SI-2996388
Mesa Laboratories Non-GAAP EPS of $2.35 beats by $0.77, revenue of $54.29M misses by $2.76M 2023/02/06 13:40:45 Seeking Alpha
Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $2.35 beats by $0.77.Revenue of $54.29M (-0.7% Y/Y) misses by $2.76M.
Earnings Scheduled For February 6, 2023 2023/02/06 12:58:55 Benzinga
Companies Reporting Before The Bell • Cummins (NYSE: CMI ) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. • ON Semiconductor (NASDAQ: ON ) is expected to report quarterly earnings at $1.27 per share on revenue of $2.08 billion. • Neurocrine Biosciences (NASDAQ: NBIX ) is likely to report quarterly earnings at $1.14 per share on revenue of $409.09 million. • Affiliated Managers Group (NYSE: AMG ) is projected to report quarterly earnings at $7.06 per share on revenue of $589.28 million. • Tyson Foods (NYSE: TSN ) is expected to report quarterly earnings at $1.36 per share on revenue of $13.52 billion. • Energizer Hldgs (NYSE: ENR ) is estimated to report quarterly earnings at $0.76 per share on revenue of $785.86 million. • IDEXX Laboratories (NASDAQ: IDXX ) is projected to report quarterly earnings at $1.94 per share on revenue of $820.91 million. • CNA Financial (NYSE: CNA ) is estimated to report quarterly earnings at $0.97 per share on revenue of $2.28 billion. • NAPCO Security Techs (NASDAQ: NSSC ) is expected to report quarterly earnings at $0.14 per share on revenue of $39.14 million. • Daseke (NASDAQ: DSKE ) is estimated to report quarterly earnings at $0.06 per share on revenue of $397.07 million. • Loews (NYSE: L ) is projected to report earnings for its fourth quarter. • Alico (NASDAQ: ALCO ) is likely to report quarterly loss at $0.31 per share on revenue of $8.10 million. • Graham (NYSE: GHM ) is estimated to report quarterly loss at $0.10 per share on revenue of $30.00 million. • Timken (NYSE: TKR ) is expected to report quarterly earnings at $1.09 per share on revenue of $1.09 billion. • ORIX (NYSE: IX ) is estimated to report earnings for its third quarter. • Mesa Laboratories (NASDAQ: MLAB ) is likely to report quarterly earnings at $0.14 per share on revenue of $57.74 million.
Mesa Laboratories: Q4 Earnings Insights 2022/05/31 13:42:51 Benzinga
Mesa Laboratories (NASDAQ: MLAB ) reported its Q4 earnings results on Tuesday, May 31, 2022 at 08:00 AM. Here''s what investors need to know about the announcement. Earnings Mesa Laboratories beat estimated earnings by 362.5%, reporting an EPS of $2.22 versus … Full story available on Benzinga.com
Mesa Laboratories GAAP EPS of -$0.34 misses by $0.82, revenue of $58.88M beats by $2.58M 2022/05/31 12:12:31 Seeking Alpha
Mesa Laboratories press release (MLAB): Q4 GAAP EPS of -$0.34 misses by $0.82.Revenue of $58.88M (+55.1% Y/Y) beats by $2.58M.
Mesa Laboratories goes ex-dividend tomorrow 2022/05/26 15:23:23 Seeking Alpha
Mesa Laboratories (MLAB) had declared $0.16/share quarterly dividend, in line with previous. Payable June 15; for shareholders of record May 31; ex-div May 27.
Mesa Laboratories Non-GAAP EPS of $1.36 beats by $0.04, revenue of $54.69M beats by $10.22M 2022/02/03 14:12:41 Seeking Alpha
Mesa Laboratories press release (MLAB): Q3 Non-GAAP EPS of $1.36 beats by $0.04.Revenue of $54.69M (+60.1% Y/Y) beats by $10.22M.
Mesa Laboratories, Inc. Shares Close in on 52-Week High - Market Mover 2022/01/04 13:26:57 Kwhen Finance
Mesa Laboratories, Inc. (MLAB) shares closed today at 1.3% below its 52 week high of $333.42, giving the company a market cap of $1B. The stock is currently up 0.3% year-to-date, up 15.1% over the past 12 months, and up 170.0% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%. Trading Activity Trading volume this week was 71.7% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -49.8% The company's stock price performance over the past 12 months lags the peer average by -49.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -17683.1% higher than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.